SWOG clinical trial number
SWOG-8012

Treatment for Advanced Adenocarcinoma and Large Cell Carcinoma of the Lung: FOMi vs CAP vs FOMi/CAP

Closed
Phase
Published
Abbreviated Title
Treatment for Advanced Adenocarcinoma and Large Cell Carcinoma of the Lung: FOMi vs CAP vs FOMi/CAP
Activated
08/04/1980
Closed
12/23/1982

Publication Information Expand/Collapse

1994

Current management of unresectable non-small cell lung cancer

RB Livingston Seminars in Oncology 21(5)(Suppl.10):4-12

1986

Effect of alternating combination chemotherapy on survival ofambulatory patients with metastatic large cell and adenocarcinomaof the lung. A Southwest Oncology study.

TP Miller;TT Chen;RB Livingston;C Coltman, Jr;RM O'Bryan;RB Vance;G Weiss;WS Fletcher;RL Stephens JCO 4(4):502-508

1985

Phase II trial of 5-fluorouracil, vincristine, and mitomycin-C (FOMi) in metastatic bronchioalveolar cell lung cancer. A Southwest Oncology Group study.

TP Miller;RB Livingston Cancer Treat Rep 69(11):1313-1314

1983

Alternating combination chemotherapy prolongs survival for metastatic non-small cell lung cancer (NSCLC) (for the Southwest Oncology Group).

TP Miller;TT Chen ASCO, #C-733